en hu


The word pharmacognosy is derived from the Greek words φαρμακσν pharmakon (drug), and γνωσις gnosis (knowledge). The pharmacognosy deals with drugs in their crude, or unprepared, form. Crude drugs are the dried, unprepared material of plant, animal or mineral origin, used for medicine. The study of these materials under the name pharmakognosie was first developed in German-speaking areas of Europe. Nowadays, pharmacognosy includes methods of extraction, separation, and structure analysis of medicines derived from natural sources.


Due to progression of DNA sequencing it is not enough to simply purify and categorize phytochemicals from plants or secondary metabolites from fungi, but intense studies are aiming to find the protein targets in the human body and better understand their functions. The science of BIOGNOSY was coined in to synthesize our knowledge about multiple interactions of natural lead compounds with every potential targets in the human body.

The major goal of Biognosy

With the progress of molecular biology now we are able to determine not just the pharmacology, but cellular target and systemic effects of increasing dose of a particular natural substance. Also, we can judge whether these phytochemicals are toxic above a certain concentration level? Moreover, the knowledge of the genome, the genetic map of human provided us clues which target a natural pharmacophore may interact with? How this interaction may safeguard us due to either health preservation or save our life in different diseases.

Alzheimer disease

Under construction.

Parkinson disease

Under construction.

Diabetes Type 2

Under construction.

Age related macula
degeneration (AMD)

Under construction.

Gene Therapy of Pain

Under construction.